Mayo Clinic researchers have found that carrying a common genetic disorder doubles the risk of developing lung cancer in smokers and nonsmokers.

The genetic disorder, alpha-1 antitrypsin deficiency (fN1ATD), could explain some 12 percent of lung cancer patients, they suggest.